GVK Biosciences said this week that the US Food and Drug Administration has renewed its license to the Hyderabad, India-based firm's clinical biomarker database.

GVK Bio said that the FDA’s biomarker qualification group renewed its license to the GVK BIO Online Biomarker Database, or GOBIOM, database.

GOBIOM contains clinically evaluated, exploratory, and preclinical biomarkers associated with different therapeutic areas that have been reported in global clinical trials, clinical, and preclinical studies.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.